These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 8903104)
1. The influence of two distinct alloresponse pathways on the design of peptide-based strategies for allograft tolerance. Benichou G; Tam RC; Soares LR; Popov IA; Garovoy MR; Fedoseyeva EV Res Immunol; 1996; 147(6):377-87. PubMed ID: 8903104 [No Abstract] [Full Text] [Related]
2. Indirect T cell recognition in allograft rejection. Bradley JA Int Rev Immunol; 1996; 13(3):245-55. PubMed ID: 8782745 [TBL] [Abstract][Full Text] [Related]
3. Inducing unresponsiveness in allopeptide specific T cells: are altered peptide ligands the answer? Jones ND Transplantation; 2000 Aug; 70(4):566-7. PubMed ID: 10972208 [No Abstract] [Full Text] [Related]
4. The importance of the indirect pathway of allorecognition in clinical transplantation. Gökmen MR; Lombardi G; Lechler RI Curr Opin Immunol; 2008 Oct; 20(5):568-74. PubMed ID: 18655831 [TBL] [Abstract][Full Text] [Related]
5. Indirect recognition of allo MHC peptides--potential role in human transplantation. Watschinger B Nephrol Dial Transplant; 1999 Jan; 14(1):8-11. PubMed ID: 10052462 [No Abstract] [Full Text] [Related]
6. Role of indirect allorecognition in allograft rejection. Sayegh MH; Carpenter CB Int Rev Immunol; 1996; 13(3):221-9. PubMed ID: 8782743 [TBL] [Abstract][Full Text] [Related]
7. Allopeptides and the alloimmune response. Bharat A; Mohanakumar T Cell Immunol; 2007 Jul; 248(1):31-43. PubMed ID: 18023633 [TBL] [Abstract][Full Text] [Related]
8. Pathways of major histocompatibility complex allorecognition. Afzali B; Lombardi G; Lechler RI Curr Opin Organ Transplant; 2008 Aug; 13(4):438-44. PubMed ID: 18685342 [TBL] [Abstract][Full Text] [Related]
9. Peptide analogues as a strategy to induce tolerance in T cells with indirect allospecificity. Frasca L; Tamir A; Jurcevic S; Marinari B; Monizio A; Sorrentino R; Carbonari M; Piccolella E; Lechler RI; Lombardi G Transplantation; 2000 Aug; 70(4):631-40. PubMed ID: 10972222 [TBL] [Abstract][Full Text] [Related]
10. The contribution of peptides to T cell allorecognition and allograft rejection. Benichou G; Fedoseyeva EV Int Rev Immunol; 1996; 13(3):231-43. PubMed ID: 8782744 [No Abstract] [Full Text] [Related]
11. Direct and indirect antigen recognition: the pathways to allograft immune rejection. Benichou G Front Biosci; 1999 May; 4():D476-80. PubMed ID: 10331992 [TBL] [Abstract][Full Text] [Related]
12. Direct and indirect allorecognition. Hornick P Methods Mol Biol; 2006; 333():145-56. PubMed ID: 16790850 [TBL] [Abstract][Full Text] [Related]
13. Mechanisms of unresponsiveness to alloantigens in vivo. Wood KJ Transplant Proc; 1998 Aug; 30(5):2430-1. PubMed ID: 9723526 [No Abstract] [Full Text] [Related]
14. Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction. Vella JP; Spadafora-Ferreira M; Murphy B; Alexander SI; Harmon W; Carpenter CB; Sayegh MH Transplantation; 1997 Sep; 64(6):795-800. PubMed ID: 9326400 [TBL] [Abstract][Full Text] [Related]
15. Rejection of the kidney allograft. Nankivell BJ; Alexander SI N Engl J Med; 2010 Oct; 363(15):1451-62. PubMed ID: 20925547 [No Abstract] [Full Text] [Related]
16. Antigen processing and presentation in transplantation. Auchincloss H; Sultan H Curr Opin Immunol; 1996 Oct; 8(5):681-7. PubMed ID: 8902394 [TBL] [Abstract][Full Text] [Related]
17. Direct and indirect pathways of alloantigen recognition: relevance to acute and chronic allograft rejection. Hornick P; Lechler R Nephrol Dial Transplant; 1997 Sep; 12(9):1806-10. PubMed ID: 9306324 [No Abstract] [Full Text] [Related]